Acquiring Company
Crown NL Bidco B.V
Acquired Company
QIAGEN
NetherlandsBiotechnologyHealth CareScience And EngineeringInternet ServicesDescription
QIAGEN N.V. entered a Business Combination Agreement with Crown NL Bidco B.V., which will make a voluntary public tender offer for all QIAGEN shares at EUR 46.50 per share in cash. The transaction values QIAGEN at approximately EUR 10.8 billion in enterprise value. QIAGEN's Supervisory and Managing Boards unanimously approved the agreement and will recommend that shareholders tender their shares.
Who to call at Crown NL Bidco B.V, and when
When Crown NL Bidco B.V changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Crown NL Bidco B.V raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Crown NL Bidco B.V, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Crown NL Bidco B.V makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired QIAGEN?
QIAGEN was acquired by Crown NL Bidco B.V, based in Netherlands. The deal was reported on October 21, 2026. Crown NL Bidco B.V. is a holding company indirectly controlled by the EQT XI fund (EQT Private Equity). Crown NL Bidco B.V is privately held.
When did Crown NL Bidco B.V acquire QIAGEN?
Crown NL Bidco B.V's acquisition of QIAGEN was reported on October 21, 2026. QIAGEN N.V. entered a Business Combination Agreement with Crown NL Bidco B.V., which will make a voluntary public tender offer for all QIAGEN shares at EUR 46.50 per share in cash. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does QIAGEN do?
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.